In collaboration with researchers in South Korea, a team from The Hospital for Sick Children (SickKids) has discovered a ...
“Interestingly, BIRC5 and MCL-1 have both been reported to be over-expressed and strongly correlated with progression and ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.
In most cases, the damage is linked to mutations in the OPA1 gene, which interfere with mitochondrial function (how cells make energy and stay healthy). New research led by Thomas Schwarz, Ph.D., and ...
Researchers have discovered a way to slow the progression of Huntington's disease by blocking SLC4A7 proteins that form neural connections.
A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results